<img alt="" src="https://secure.perk0mean.com/184504.png" style="display:none;">
Skip to content
Request a Demo

Blog

June 23, 2022
Prediction for 2022: Real-time drug tracking will start becoming an industry standard

  Prediction for 2022: Real-time drug tracking will start becoming an industry standard Be sure to listen to the January 2022 episode of the Trial Trends podcast, "3 Trends...

Learn More
June 23, 2022
3 Simple Steps to Manage Multiple Protocol Versions in a Single Study

Managing protocol versions at the site level and the broader protocol amendment at the sponsor level go hand-in-hand. Neither is simple, but both sides of the equation must...

Learn More
June 22, 2022
Master Protocol Studies – A Map to an Unknown Destination

Learn More

Filter by Topic

January 13, 2022
Prediction for 2022: Real-time drug tracking will start becoming an industry standard
Read More
October 1, 2021
Why I Do This - Elana Rose
Read More
September 15, 2021
A Metastatic Breast Cancer (MBC) Patient’s Journey to ‘No Active Disease’
Read More
September 1, 2021
A Rare Disease Patient Sheds Light on Journey for Treatment
Read More
September 30, 2020
Is Direct-to-Patient (DtP) the Tip of the Virtual Trial Iceberg?
Read More
September 24, 2020
5 Questions You Never Ask Your RTSM Vendor, But Should
Read More
September 10, 2020
Direct-to-Patient (DtP) in Review – What Would We Have Done Differently if We Knew COVID-19 was Coming?
Read More
May 29, 2020
5 Supply Chain Impacts Resulting from Master Protocol Amendments – And How to Prepare
Read More
May 15, 2020
3 Simple Steps to Manage Multiple Protocol Versions in a Single Study
Read More